According to an FDA letter dated February 5, the agency stated that the advertisement “misbrands†Wegovy.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
FDA Says Novo's Wegovy Pill TV Advertisement Is Misleading: NVO Stock Pares Gains